Keywords
UGT1A1 - sacituzumab govitecan - toxicity - irinotecan
Bibliographical Record
Isabella Michelon, Jonathan Priantti, Caio Ernesto do Rego Castro, Thiago Madeira,
Gilca Costa Nachtigal. Safety analysis according to UGT1A1 status in patients treated
with sacituzumab govitecan: a systematic review and meta-analysis. Brazilian Journal
of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807914
